Field safety notices: Vivostat
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
1 authority publication by one authority, from 26 Nov 2020 to 26 Nov 2020.
Latest notice: 26 Nov 2020, AEMPS, Reactivos estériles Citrato/TA-fibrina (vial 20 mL), Citrato/TA-PRF (vial 20 ml) y pH 10 (vial 5 ml) incluidos en todos los sets y kits de aplicación Vivostat (ver códigos de producto en nota de aviso empresa)
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Vivostat or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
1 distinct corrective action.
- Reactivos estériles Citrato/TA-fibrina (vial 20 mL), Citrato/TA-PRF (vial 20 ml) y pH 10 (vial 5 ml) incluidos en todos los sets y kits de aplicación Vivostat (ver códigos de producto en nota de aviso empresa)
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026